Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway
Background Immunosuppressive phenotype compromised immunotherapy efficacy of hepatocellular carcinoma. Tumor cells intrinsic mitochondria dynamics could pass effects on the extracellular microenvironment through mtDNA stress. PGAM5 anchors at mitochondria and regulates mitochondria functions. We aim...
Saved in:
Main Authors: | Yan Li, Hong Wang, Xiaoyang Li, Yuan He, Huiquan Liu, Dong Han, Ting Mei, Yixuan Li, Zilong Xu, Xiaoying Wei, Jianguo Wang, Peijie Zhou, Yuwen Wang, Ziye Li, Junhao Ning, Anlin Wang, Jingjing Cheng, Dong Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e009993.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiological and pathological roles of PGAM5: An update and future trend
by: Weibin He, et al.
Published: (2025-02-01) -
ROS-induced cytosolic release of mitochondrial PGAM5 promotes colorectal cancer progression by interacting with MST3
by: Shiyang Wang, et al.
Published: (2025-02-01) -
Intrinsic PD‐L1 Degradation Induced by a Novel Self‐Assembling Hexapeptide for Enhanced Cancer Immunotherapy
by: Hongxia Zhang, et al.
Published: (2025-01-01) -
Leakage Performance of the GM + CCL Liner System for the MSW Landfill
by: Fan Jingjing
Published: (2014-01-01) -
Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01)